Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1957 (Rev 10/2011) |
OMB No. 0651-0050 (Exp 09/20/2020) |
Response to Office Action
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
88338264 |
LAW OFFICE ASSIGNED |
LAW OFFICE 109 |
MARK SECTION |
MARK |
http://uspto.report/TM/88338264/mark.png |
LITERAL ELEMENT |
KEYSTONE |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
MARK STATEMENT |
The mark consists of standard characters, without claim to any particular font style, size or color. |
ARGUMENT(S) |
Please see the actual argument text attached within the Evidence section. |
EVIDENCE SECTION |
EVIDENCE FILE NAME(S) |
ORIGINAL PDF FILE |
evi_1-104129194195-20191124145140520601_._Response_to_Office_Action-_KEYSTONE__88338264_.pdf |
CONVERTED PDF FILE(S)
(12 pages) |
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0002.JPG |
|
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0003.JPG |
|
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0004.JPG |
|
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0005.JPG |
|
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0006.JPG |
|
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0007.JPG |
|
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0008.JPG |
|
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0009.JPG |
|
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0010.JPG |
|
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0011.JPG |
|
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0012.JPG |
|
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0013.JPG |
ORIGINAL PDF FILE |
evi_1-104129194195-20191124145140520601_._Exhibit_A-_KEYSTONE.pdf |
CONVERTED PDF FILE(S)
(4 pages) |
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0014.JPG |
|
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0015.JPG |
|
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0016.JPG |
|
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0017.JPG |
ORIGINAL PDF FILE |
evi_1-104129194195-20191124145140520601_._Exhibit_B-_KEYSTONE.pdf |
CONVERTED PDF FILE(S)
(7 pages) |
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0018.JPG |
|
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0019.JPG |
|
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0020.JPG |
|
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0021.JPG |
|
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0022.JPG |
|
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0023.JPG |
|
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0024.JPG |
ORIGINAL PDF FILE |
evi_1-104129194195-20191124145140520601_._Exhibit_C-_KEYSTONE.pdf |
CONVERTED PDF FILE(S)
(3 pages) |
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0025.JPG |
|
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0026.JPG |
|
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0027.JPG |
ORIGINAL PDF FILE |
evi_1-104129194195-20191124145140520601_._Exhibit_D-_KEYSTONE.pdf |
CONVERTED PDF FILE(S)
(3 pages) |
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0028.JPG |
|
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0029.JPG |
|
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0030.JPG |
ORIGINAL PDF FILE |
evi_1-104129194195-20191124145140520601_._Exhibit_E-_KEYSTONE.pdf |
CONVERTED PDF FILE(S)
(4 pages) |
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0031.JPG |
|
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0032.JPG |
|
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0033.JPG |
|
\\TICRS\EXPORT17\IMAGEOUT17\883\382\88338264\xml4\ROA0034.JPG |
DESCRIPTION OF EVIDENCE FILE |
Response to Office Action dated May 29, 2019 and exhibits |
GOODS AND/OR SERVICES SECTION (current) |
INTERNATIONAL CLASS |
042 |
DESCRIPTION |
Clinical trials in the field of hemophilia, medical research, education, and patient advocacy services all related to hemophilia |
FILING BASIS |
Section 1(b) |
GOODS AND/OR SERVICES SECTION (proposed) |
INTERNATIONAL CLASS |
042 |
TRACKED TEXT DESCRIPTION |
Clinical trials in the field of hemophilia, medical research, education, and patient advocacy services
all related to hemophilia; Conducting clinical trials in the field of hemophilia; providing medical research information in
the field of clinical trials in relation to hemophilia; medical research in the field of hemophilia |
FINAL DESCRIPTION |
Conducting clinical trials in the field of hemophilia; providing medical research information in the field of clinical trials in
relation to hemophilia; medical research in the field of hemophilia |
FILING BASIS |
Section 1(b) |
ATTORNEY SECTION (current) |
NAME |
Jamie B. Bischoff |
ATTORNEY BAR MEMBERSHIP NUMBER |
NOT SPECIFIED |
YEAR OF ADMISSION |
NOT SPECIFIED |
U.S. STATE/ COMMONWEALTH/ TERRITORY |
NOT SPECIFIED |
INTERNAL ADDRESS |
BALLARD SPAHR LLP |
STREET |
1735 MARKET STREET, 51ST FLOOR |
CITY |
PHILADELPHIA |
STATE |
Pennsylvania |
POSTAL CODE |
19103-7599 |
COUNTRY |
US |
PHONE |
215-864-8207 |
FAX |
215.864.8999 |
EMAIL |
bischoff@ballardspahr.com |
AUTHORIZED TO COMMUNICATE VIA EMAIL |
Yes |
DOCKET/REFERENCE NUMBER |
00305922 |
ATTORNEY SECTION (proposed) |
NAME |
Jamie B. Bischoff |
ATTORNEY BAR MEMBERSHIP NUMBER |
XXX |
YEAR OF ADMISSION |
XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY |
XX |
INTERNAL ADDRESS |
BALLARD SPAHR LLP |
STREET |
1735 MARKET STREET, 51ST FLOOR |
CITY |
PHILADELPHIA |
STATE |
Pennsylvania |
POSTAL CODE |
19103-7599 |
COUNTRY |
United States |
PHONE |
2156658500 |
FAX |
215.864.8999 |
EMAIL |
tmdocketing@ballardspahr.com |
AUTHORIZED TO COMMUNICATE VIA EMAIL |
Yes |
DOCKET/REFERENCE NUMBER |
00305922 |
OTHER APPOINTED ATTORNEY |
all of the firm of Ballard Spahr LLP |
CORRESPONDENCE SECTION (current) |
NAME |
JAMIE B. BISCHOFF |
INTERNAL ADDRESS |
BALLARD SPAHR LLP |
STREET |
1735 MARKET STREET, 51ST FLOOR |
CITY |
PHILADELPHIA |
STATE |
Pennsylvania |
POSTAL CODE |
19103-7599 |
COUNTRY |
US |
PHONE |
215-864-8207 |
FAX |
215.864.8999 |
EMAIL |
bischoff@ballardspahr.com; phila_tmdocketing@ballardspahr.com |
AUTHORIZED TO COMMUNICATE VIA EMAIL |
Yes |
DOCKET/REFERENCE NUMBER |
00305922 |
CORRESPONDENCE SECTION (proposed) |
NAME |
Jamie B. Bischoff |
FIRM NAME |
Ballard Spahr LLP |
INTERNAL ADDRESS |
1735 Market Street, 51st Floor |
STREET |
1735 Market Street, 51st Floor |
CITY |
Philadelphia |
STATE |
Pennsylvania |
POSTAL CODE |
19103-7599 |
COUNTRY |
United States |
PHONE |
2156658500 |
FAX |
215.864.8999 |
EMAIL |
tmdocketing@ballardspahr.com; curciot@ballardspahr.com |
AUTHORIZED TO COMMUNICATE VIA EMAIL |
Yes |
DOCKET/REFERENCE NUMBER |
00305922 |
SIGNATURE SECTION |
RESPONSE SIGNATURE |
/tmc/ |
SIGNATORY'S NAME |
Tanya Marie Curcio |
SIGNATORY'S POSITION |
Attorney, Ballard Spahr, New York bar member |
SIGNATORY'S PHONE NUMBER |
215-864-8864 |
DATE SIGNED |
11/24/2019 |
AUTHORIZED SIGNATORY |
YES |
FILING INFORMATION SECTION |
SUBMIT DATE |
Sun Nov 24 15:08:32 EST 2019 |
TEAS STAMP |
USPTO/ROA-XXX.XXX.XXX.XXX
-20191124150832143655-883
38264-70035f033da7e6b4d99
1cd937a3871e0549ad59952bf
d979b467a9fa76764729-N/A-
N/A-20191124145140520601 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1957 (Rev 10/2011) |
OMB No. 0651-0050 (Exp 09/20/2020) |
Response to Office Action
To the Commissioner for Trademarks:
Application serial no.
88338264 KEYSTONE(Standard Characters, see http://uspto.report/TM/88338264/mark.png) has been amended as follows:
ARGUMENT(S)
In response to the substantive refusal(s), please note the following:
Please see the actual argument text attached within the Evidence section.
EVIDENCE
Evidence in the nature of Response to Office Action dated May 29, 2019 and exhibits has been attached.
Original PDF file:
evi_1-104129194195-20191124145140520601_._Response_to_Office_Action-_KEYSTONE__88338264_.pdf
Converted PDF file(s) ( 12 pages)
Evidence-1
Evidence-2
Evidence-3
Evidence-4
Evidence-5
Evidence-6
Evidence-7
Evidence-8
Evidence-9
Evidence-10
Evidence-11
Evidence-12
Original PDF file:
evi_1-104129194195-20191124145140520601_._Exhibit_A-_KEYSTONE.pdf
Converted PDF file(s) ( 4 pages)
Evidence-1
Evidence-2
Evidence-3
Evidence-4
Original PDF file:
evi_1-104129194195-20191124145140520601_._Exhibit_B-_KEYSTONE.pdf
Converted PDF file(s) ( 7 pages)
Evidence-1
Evidence-2
Evidence-3
Evidence-4
Evidence-5
Evidence-6
Evidence-7
Original PDF file:
evi_1-104129194195-20191124145140520601_._Exhibit_C-_KEYSTONE.pdf
Converted PDF file(s) ( 3 pages)
Evidence-1
Evidence-2
Evidence-3
Original PDF file:
evi_1-104129194195-20191124145140520601_._Exhibit_D-_KEYSTONE.pdf
Converted PDF file(s) ( 3 pages)
Evidence-1
Evidence-2
Evidence-3
Original PDF file:
evi_1-104129194195-20191124145140520601_._Exhibit_E-_KEYSTONE.pdf
Converted PDF file(s) ( 4 pages)
Evidence-1
Evidence-2
Evidence-3
Evidence-4
CLASSIFICATION AND LISTING OF GOODS/SERVICES
Applicant proposes to amend the following class of goods/services in the application:
Current: Class 042 for Clinical trials in the field of hemophilia, medical research, education, and patient advocacy services all related to hemophilia
Original Filing Basis:
Filing Basis: Section 1(b), Intent to Use: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was
entitled, to use the mark in commerce on or in connection with the identified goods/services in the application.
For a collective trademark, collective service mark, or collective membership
mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members
on or in connection with the identified goods/services/collective membership organization.
For a certification mark application: As of the application filing date, the applicant had a
bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, and the applicant will
not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that
meet the certification standards of the applicant.
Proposed:
Tracked Text Description: Clinical trials in the field of hemophilia, medical research, education, and patient advocacy services all related to hemophilia;
Conducting clinical trials in the field of hemophilia;
providing medical research information in the field of clinical trials in
relation to hemophilia;
medical research in the field of hemophiliaClass 042 for Conducting clinical trials in the field of hemophilia; providing medical
research information in the field of clinical trials in relation to hemophilia; medical research in the field of hemophilia
Filing Basis: Section 1(b), Intent to Use: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was
entitled, to use the mark in commerce on or in connection with the identified goods/services in the application.
For a collective trademark, collective service mark, or collective membership
mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members
on or in connection with the identified goods/services/collective membership organization.
For a certification mark application: As of the application filing date, the applicant had a
bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, and the applicant will
not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that
meet the certification standards of the applicant.
The applicant's current attorney information: Jamie B. Bischoff. Jamie B. Bischoff, is located at
BALLARD SPAHR LLP
1735 MARKET STREET, 51ST FLOOR
PHILADELPHIA, Pennsylvania 19103-7599
US
The docket/reference number is 00305922.
The phone number is 215-864-8207.
The fax number is 215.864.8999.
The email address is bischoff@ballardspahr.com
The applicants proposed attorney information: Jamie B. Bischoff. Other appointed attorneys are all of the firm of Ballard Spahr LLP. Jamie B. Bischoff, is a member of the XX bar, admitted to the
bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
BALLARD SPAHR LLP
1735 MARKET STREET, 51ST FLOOR
PHILADELPHIA, Pennsylvania 19103-7599
United States
The docket/reference number is 00305922.
The phone number is 2156658500.
The fax number is 215.864.8999.
The email address is tmdocketing@ballardspahr.com
Jamie B. Bischoff submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S.
Commonwealth or territory.
The applicant's current correspondence information: JAMIE B. BISCHOFF. JAMIE B. BISCHOFF, is located at
BALLARD SPAHR LLP
1735 MARKET STREET, 51ST FLOOR
PHILADELPHIA, Pennsylvania 19103-7599
US
The docket/reference number is 00305922.
The phone number is 215-864-8207.
The fax number is 215.864.8999.
The email address is bischoff@ballardspahr.com; phila_tmdocketing@ballardspahr.com
The applicants proposed correspondence information: Jamie B. Bischoff. Jamie B. Bischoff of Ballard Spahr LLP, is located at
1735 Market Street, 51st Floor
1735 Market Street, 51st Floor
Philadelphia, Pennsylvania 19103-7599
United States
The docket/reference number is 00305922.
The phone number is 2156658500.
The fax number is 215.864.8999.
The email address is tmdocketing@ballardspahr.com; curciot@ballardspahr.com
SIGNATURE(S)
Response Signature
Signature: /tmc/ Date: 11/24/2019
Signatory's Name: Tanya Marie Curcio
Signatory's Position: Attorney, Ballard Spahr, New York bar member
Signatory's Phone Number: 215-864-8864
The signatory has confirmed that he/she is a U.S.-licensed attorney who is an active member in good standing of the bar of the highest court of a U.S. state (including the District of Columbia and
any U.S. Commonwealth or territory); and he/she is currently the owner's/holder's attorney or an associate thereof; and to the best of his/her knowledge, if prior to his/her appointment another
U.S.-licensed attorney not currently associated with his/her company/firm previously represented the owner/holder in this matter: the owner/holder has revoked their power of attorney by a signed
revocation or substitute power of attorney with the USPTO; the USPTO has granted that attorney's withdrawal request; the owner/holder has filed a power of attorney appointing him/her in this matter;
or the owner's/holder's appointed U.S.-licensed attorney has filed a power of attorney appointing him/her as an associate attorney in this matter.
Mailing Address: JAMIE B. BISCHOFF
BALLARD SPAHR LLP
1735 MARKET STREET, 51ST FLOOR
PHILADELPHIA, Pennsylvania 19103-7599
Mailing Address: Jamie B. Bischoff
Ballard Spahr LLP
1735 Market Street, 51st Floor
1735 Market Street, 51st Floor
Philadelphia, Pennsylvania 19103-7599
Serial Number: 88338264
Internet Transmission Date: Sun Nov 24 15:08:32 EST 2019
TEAS Stamp: USPTO/ROA-XXX.XXX.XXX.XXX-20191124150832
143655-88338264-70035f033da7e6b4d991cd93
7a3871e0549ad59952bfd979b467a9fa76764729
-N/A-N/A-20191124145140520601